DJIA 16,461.32 -153.49 -0.92%
NASDAQ 4,382.85 -36.63 -0.83%
S&P 500 1,927.11 -14.17 -0.73%
market minute promo

Eli Lilly & Co. (NYSE: LLY)

64.68 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

LLY $64.68 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $64.59
Previous Close $64.68
Daily Range $64.58 - $65.30
52-Week Range $48.88 - $67.14
Market Cap $72.3B
P/E Ratio 20.53
Dividend (Yield) $1.96 (3.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 4,294,483
Average Daily Volume 4,116,043
Current FY EPS $2.76





Eli Lilly & Co. (LLY) Description

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases. Website:

News & Commentary

Is It Time to Buy Eli Lilly & Co.'s Stock?

Eli Lilly & Co. is promising big things, but has optimism in the stock gotten ahead of reality? It's time to ask if now's the right time to invest.

CANDA NK-2 Files Motion To Dismiss Patent Infringement Suit

Lilly, Zymeworks Announce Expansion Of Strategic Licensing And Collaboration Agreement

Pre-Market Earnings Report for October 23, 2014 : CMCSA, UNP, MMM, CELG, LLY, OXY, CAT, GM, ALXN, P

Pre-Market Earnings Report for October 23, 2014 : CMCSA, UNP, MMM, CELG, LLY, OXY, CAT, GM, ALXN, PCP, RTN, POT

Daily Dividend Report: AAPL, ABBV, AEP, WPZ, LLY, SO, NSC, EXC, ETN, NBL, WHR, CCE, LLL, HLS

MannKind Corporation's Investors Shouldn't Dance Around This Issue

It's not a good sign that MannKind's competitor can't IPO.

Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?

The world's largest pharmaceutical company, Pfizer, looks lost amid its staggering patent cliff problem. Could this experimental breast cancer drug put Pfizer back on track for growth?

Lilly Announces Plan to Realign Puerto Rico Manufacturing Operations

XLV, MDT, LLY, AGN: Large Outflows Detected at ETF

Can Dividend Stock GlaxoSmithKline plc Bounce Back?

British pharma GlaxoSmithKline is being accused of corruption in yet another country, the United Arab Emirates. Given all the problems facing the company these days, can Glaxo turn things around?

See More LLY News...

LLY's Top Competitors

LLY $64.68 (0.00%)
Current stock: LLY
JNJ $101.22 (0.86%)
Current stock: JNJ
NVS $88.20 (-0.46%)
Current stock: NVS
RHHBY $36.36 (-0.10%)
Current stock: RHHBY